A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME

Clinical trial NCT06708260 · RECRUITING

Trial details

NCT number: NCT06708260
Sponsor: EnnovaBio
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)

Start date: 2024-12-12
Primary completion: 2025-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.